GPT2: The Glutamic--alanine Transaminase 2 Enigma (G84706)

Target Name: GPT2

NCBI ID: G84706

GPT2: The Glutamic--alanine Transaminase 2 Enigma

Gut microbiota have been shown to play a crucial role in the development and progression of various diseases, including inflammatory disorders, obesity, and neurological diseases. One of the key enzymes involved in the gut-brain axis is GPT2, a glutamic acid decarboxylase that is expressed high in the human gut microbiota. Despite its importance, the exact function of GPT2 in the gut-brain axis remains poorly understood.

GPT2, also known as GLUTAMYL TRANSAMINASE 2, is a transmembrane protein that is expressed in the intestinal epithelial cells of the gut. It is a key enzyme in the gut-brain axis, as it is involved in the production of glutamylamine, a crucial signaling molecule in the gut-brain axis. GPT2 has also been shown to be involved in the regulation of inflammation, immune cell function, and metabolism.

Recent studies have suggested that GPT2 may be a potential drug target or biomarker for various neurological and psychiatric disorders. GPT2 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, by promoting the production of pro-inflammatory cytokines.

In addition, GPT2 has also been shown to be involved in the development of obesity and type 2 diabetes by promoting the production of energy-dense nutrients, such as glucose and lipids, in the gut. Furthermore, GPT2 has been shown to play a role in the regulation of pain perception and neuroinflammation.

GPT2 has also been shown to be involved in the regulation of mood and anxiety by modulating the activity of neural circuits in the brain. In addition, GPT2 has been shown to be involved in the regulation of cognitive function by modulating the activity of neural circuits in the brain.

Despite its importance in the gut-brain axis, the exact function of GPT2 is not well understood. GPT2 has been shown to be involved in the production of various signaling molecules, including neurotransmitters, cytokines, and chemokines. However, the precise mechanisms by which GPT2 modulates these signaling pathways are not well understood.

One possible mechanism by which GPT2 may be involved in modulating neurotransmitter signaling is through its role in the production of glutamylamine, which has been shown to play a role in the regulation of neurotransmitter release and signaling. Glutamylamine has been shown to modulate the activity of various neurotransmitter receptors, including dopamine, serotonin, and GABA, by modulating the activity of GPT2.

Another potential mechanism by which GPT2 may be involved in modulating neurotransmission is through its role in the regulation of ion channels in the brain. GPT2 has been shown to be involved in the regulation of the activity of Na+ and K+ channels in the brain, which may play a role in modulating neurotransmission.

In addition, GPT2 may also be involved in the regulation of inflammation and immune cell function. GPT2 has been shown to be involved in the production of pro-inflammatory cytokines, such as TNF-alpha and IL-8, by promoting the production of microRNA-29 (miRNA-29). miRNA-29 has been shown to play a role in the regulation of inflammation and immune cell function, and GPT2 may be involved in the regulation of its activity by modulating the activity of GPT2.

GPT2 may also be involved in

Protein Name: Glutamic--pyruvic Transaminase 2

Functions: Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate

More Common Targets